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Cell migrationCell adhesion to the extracellular matrix proteins occurs through interactions with integrins that bind to
Arg-Gly-Asp (RGD) tripeptides, and syndecan-4, which recognizes the heparin-binding domain of other
proteins. Both receptors trigger signaling pathways, including those that activate RhoGTPases such
as RhoA and Rac1. This sequence of events modulates cell adhesion to the ECM and cell migration. Using a neu-
ron–astrocyte model, we have reported that the neuronal protein Thy-1 engages αVβ3 integrin and syndecan-4
to induce RhoA activation and strong astrocyte adhesion to their underlying substrate. Thus, because cell–cell inter-
actions and strong cell attachment to thematrix are considered antagonistic to cellmigration, we hypothesized that
Thy-1 stimulation of astrocytes should preclude cell migration. Here, we studied the effect of Thy-1 expressing neu-
rons on astrocyte polarization and migration using a wound-healing assay and immunoﬂuorescence analysis. Sig-
naling molecules involved were studied by afﬁnity precipitation, western blotting and the usage of speciﬁc
antibodies. Intriguingly, Thy-1 interaction with its two receptors was found to increase astrocyte polarization and
migration. The latter events required interactions of these receptors with both the RGD-like sequence and the
heparin-binding domain of Thy-1. Additionally, prolonged Thy-1-receptor interactions inhibited RhoA activation
while activating FAK, PI3K andRac1. Therefore, sustained engagement of integrin and syndecan-4with theneuronal
surface protein Thy-1 induces astrocytemigration. Interestinglywe identify here, a cell–cell interaction that despite
initially inducing strong cell attachment, favors cellmigration uponpersistent stimulation by engaging the same sig-
naling receptors and molecules as those utilized by the extracellular matrix proteins to stimulate cell movement.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
The Thy-1-integrin interaction, initially described to mediate
neuron–astrocyte communication [1], has set the basis for various
reports showing interactions in Trans of Thy-1 with integrin recep-
tors containing β2 or β3 subunits [2]. Indeed, Thy-1 interacts with
αXβ2 integrin, an integrin highly expressed on the surface of dendrit-
ic cells [3] and with αVβ3 in melanoma cells mediating their adhe-
sion to activated endothelium [4]. In astrocytes, αVβ3 integrin
directly binds to the tripeptide RLD present in Thy-1 [5]. In neuron–
astrocyte interaction assays, Thy-1-integrin binding recruits Focal
Adhesion Kinase (FAK) to focal contacts formed by astrocytes and acti-
vates FAK and RhoA, thereby promoting the formation of robust focallular y Molecular, Facultad de
x: +56 2 738 2015.
rights reserved.adhesions and stress ﬁbers in less than 20 min of stimulation [1,5–7].
These events, together with Thy-1-syndecan-4 interaction via the
Thy-1 heparin-binding domain (HBD), contribute to the activation of
PKCα [8]. Altogether, these observations, in conjunction with other
reports, indicate that Thy-1 plays an important role in stimulating cell
adhesion and actin cytoskeleton changes [9–12]. In our neuron–astro-
cytemodel and in view of the reported time frame of formation andmat-
uration of focal adhesions [1,5–8], the neuronal surface protein Thy-1
induces a rapid and strong astrocyte adhesion to the substratum, via a
Trans-induced signaling.
Cell migration is a multistep cycle of protrusion, adhesion to a sub-
strate, polarization to establish a leading edge and relocation of sig-
naling molecules that reorganizes the cytoskeleton and organelles in
the direction of subsequent migration, followed by cell body
movement and detachment of the rear of the cell [13,14]. Filopodia,
lamellipodia and focal contacts at the leading edge, together with ma-
ture focal adhesions and stress ﬁbers in the lateral proximity of front
protrusions provide the contraction force required to move cells.
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plete displacement of the cells [15,16]. Reportedly, cells with large
and elongated focal adhesions are less motile, whereas those rapidly
moving cells present small focal contacts that are highly dynamic
[17]. Thus, we hypothesized that Thy-1-enhanced cell adhesion neg-
atively controls migration of astrocytes.
Cell surface receptors and signaling pathways involved in cellmigra-
tion are well described for cellular locomotion induced by extracelluar
matrix (ECM) proteins, which generate intracellular signals via dual en-
gagement of both integrins and syndecan-4 receptors. The former binds
to the RGD tripeptide, while the latter engages the HBD of ECMproteins
[18–22]. Key signaling events for migration, involved downstream of
these receptors, are binding of PI3K (phosphatidylinositol 3-kinase) to
phosphorylated FAK [23] and activation of the small GTPase Rac1
[24–26].
Here, we report that the strong cell adhesion induced by neuronal
Thy-1 via its interaction with αVβ3 integrin and syndecan-4 on astro-
cytes, is decreased upon sustained stimulation with Thy-1, and thus,
contrary to all predictions, astrocyte migration on a 2D surface is en-
hanced by Thy-1. In addition, Thy-1 utilizes the same two binding
motives (RLD and HBD) involved in cell attachment to ligate its re-
ceptors and induce migration. Furthermore, prolonged Thy-1 binding
to integrin and syndecan-4 inhibits RhoA GTPase and activates the
FAK/PI3K/Rac1 signaling pathway, decreasing astrocyte adhesion
while increasing cell polarization and migration over a substratum.
Thus, a cell surface protein prevalent on neurons can trigger a cascade
of signaling events that modulates adhesion and shape as well as the
migratory capacity of astrocytes.
2. Materials and methods
2.1. Cell culture and transfections
The rat astrocytic cell line DI TNC1 (ATCC CRL-2005) was
maintained in RPMI medium 1640 (GIBCO Life Technologies, Grand
Island, NY) as previously described [5]. Astrocytes expressing a dom-
inant negative form of Rac1 were obtained by nucleofecting the
EGFP-N17Rac1-containing plasmid following manufacturer recom-
mendations for astrocytes (Amaxa Biosystems, Lonza, Cologne, Ger-
many). CAD cells, CAD shThy-1 and CAD shLuc were maintained in
D-MEM/F12 medium (GIBCO Life Technologies, Grand Island, NY) as
described [5]. CAD cells with decreased levels of Thy-1 were obtained
by transducing the cells with lentivirus, containing the pure pLCO.1
vector, the shRNA sequence that targets Thy-1 and resistance to puro-
mycin as previously reported [27].
2.2. Antibodies and reagents
The recombinant proteins Thy-1-Fc and its mutants, as well as
TRAIL-R2-Fc were obtained as reported [1,5,8] and used coupled to
protein A (Sigma Chemical Co., St. Louis, MO) for cell stimulation.
The complexes were incubated in a 10:1 (recombinant fusion pro-
tein: Protein-A) ratio for 60 min at 4 °C, shaking gently as reported
[28]. Immunoﬂuorescence reagents were rhodamine-conjugated
phalloidin (Sigma Chemical Co., St. Louis, MO), DAPI (diamidino-
2-phenylindole) (Sigma Chemical Co., St. Louis, MO) and the anti-
bodies rabbit anti-Thy-1 (serum R287, donated by Dr. Claude
Bron, [29]), mouse anti-vinculin mAb (Sigma Chemical Co., St.
Louis, MO), rabbit anti-giantin (Covance Research Products, Denver,
PA) and goat anti-mouse IgG ﬂuorescein isothiocyanate (Jackson
ImmunoResearch Laboratories, Inc. West Grove, PA) or goat
anti-mouse IgG conjugated to Alexa ﬂuor 488 (Molecular Probes,
Eugene, OR). Other antibodies used were anti-p-Akt (Ser 473) poly-
clonal Ab (Cell Signaling Danvers, MA), anti-Akt (Cell Signaling
Danvers, MA), anti p-FAK (Tyr397) (Upstate Biotechnology, Lake
Placid, NY), anti-Rac (BD Transduction Laboratories), anti β-actin(Sigma Chemical Co., St. Louis, MO) and horseradish peroxidase-
conjugated goat anti-mouse IgG polyclonal antibody (Bio-Rad Laborato-
ries, Inc., Hercules, CA) or goat anti-rabbit IgG-HRP pAb for immunoblot
analysis. Mouse anti-αV integrin monoclonal antibody (BD Transduction
Laboratories Franklin Lakes, NJ), mouse anti-rat β3 integrin mAb (clone
F11, BD Transduction Laboratories Franklin Lakes, NJ) were used as
blocking antibodies in the wound-healing assay. The PI3K inhibitor
used was LY294002 (Sigma Chemical Co., St. Louis, MO), the Rac1 inhib-
itor was NSC 23766 (Sta. Cruz Biotechnology, Santa Cruz, CA) and the
FAK inhibitor that prevents FAK autophosphorylation at Tyr 397 was
C14 (Tocris Bioscience, Ellisville MO). Other reagents used were Heparin
(SigmaChemical Co., St. Louis,MO), CellTiter 96AQueous Non-Radioactive
Cell Proliferation Assay (Promega Madison, WI).
2.3. Proliferation assays
Astrocytes DI TNC1 were seeded in 96-well plates at a density of
3 × 103 per well and incubated for 24 h in the absence of serum.
The cells were incubated with Thy-1-Fc-Protein-A (1 μg/0.1 μg)
complexes for 16, 24, and 48 h. As negative controls TRAIL-R2-
Fc-Protein A (1 μg/0.1 μg) complexes were used while serum stim-
ulated astrocytes were employed as positive controls.
Cell proliferation was evaluated by the MTS® assay (3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfopheny-
l)-2H-tetrazolium), according to the manufacturer's (Promega, Madi-
son, WI) instructions. Since the MTS assay measures both cell
proliferation and viability, a trypan blue exclusion assay was also used
to determine cell proliferation.
2.4. In vitro wound-healing assay
Astrocytes were seeded in 24-well plates for 18 h at 70–80%
conﬂuency. Upon formation of a subconﬂuent monolayer, the wounds
were created with a sterile pipette tip. After wounding, detached cells
were eliminated by washing twice with PBS, the medium replaced
with serum-free medium RPMI, which was left for 30 min prior to
the addition of Thy-1-Fc-Protein-A (4 μg/0.4 μg) complexes. As nega-
tive controls TRAIL-R2-Fc-Protein-A at the same concentration and
non-stimulated astrocytes were used. Astrocytes stimulated with 3%
fetal bovine serum in RPMI medium were used as a positive control.
Wound closure was monitored by time-lapse microscopy with a
Carl Zeiss Axiovert-135 microscope coupled to Nikon Coolpix 995 dig-
ital camara. Images were analyzed for void area using NIH Image J
software. When using the PI3K inhibitor, LY294002 (3 μM) or Rac1
inhibitor, NSC 23766 (5 μM), the inhibitors were added to the medi-
um 30 min before addition of Thy-1-Fc/Protein-A complex. When
using anti-αV and β3 integrin blocking antibodies astrocytes were
pre-incubated for 10 min at 37 °C before the scratch was made. In
other experiments, Thy-1-Fc-Protein A was incubated with heparin
(400 μg/ml) for 30 min at 4 °C before the stimulation.
2.5. RhoA and Rac1 activity assays
Astrocytes were grown in 6 cm plates, and RhoA or Rac1 activities
were measured using afﬁnity precipitation assays. Brieﬂy, RhoA afﬁnity
precipitationwas performed usingGST-RBD as previously described [6].
For Rac1 activity measurements, cells were serum starved for 16 h and
subsequently stimulated with 40 μg of Thy-1-Fc coupled to Protein
A-Sepharose beads in 800 μl of 50% slurry for different times.
Serum-stimulation (60 min) was used as a positive control in various
experiments. Cells were harvested in 300 μl of lysis buffer [25 mM
HEPES (pH 7.4), 100 mM NaCl, 1% NP40, 5 mM MgCl2, 10% glycerol,
1 mM DTT, 10 μg/ml leupeptin, 10 μg/ml aprotinin and 1 mM sodium
orthovanadate]. Cell lysates were incubated with 30 μg of GST-PBD
beads for 15 min at 4 °C and mixed gently on a rocking shaker. Bound
proteins were resolved by SDS-PAGE in 12% Bis–Tris gels (BioRad,
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MA). Active GTP-bound RhoA or Rac1 was determined by Western
blot analysis. The fold-increase in RhoA or Rac1 activity was normalized
to total protein.
2.6. Indirect immunoﬂuorescence assays
DI TNC1 astrocytes were grown on sterile coverslips in 24-well
plates for 18 h in complete medium. The cells were incubated for
30 min in serum-free medium and subsequently stimulated with
Thy-1-Fc-Protein A (4 μg/0.4 μg). TRAIL-R2-Fc-Protein A was used as
a negative control and 3% FBS, as a positive control. Astrocytes were
ﬁxed for 20 min with 4% paraformaldehyde in 100 mM PIPES buffer,
pH 6.8, containing 0.04 M KOH, 2 mM EGTA, and 2 mM MgCl2 after
1 h of stimulation to observe formation of typical migratory struc-
tures, such as ﬁlopodia and lamellipodia, or after 7 h to follow cell
polarization. Afterwards, they were washed three times with buffer
50 mM Tris–HCl (pH 7.6), 0.15 N NaCl and 0.1% sodium azide (Uni-
versal buffer). Cells were permeabilized with 0.1% Triton X-100 in
Universal buffer for 10 min, washed twice with the same buffer, and
then blocked with 2% bovine serum albumin.
To evaluate ﬁlopodia and lamellipodia formation, cells were stained
for focal adhesions and stress ﬁbers, as previously described [1]. To
monitor cell polarization, the cells were stained with anti-giantin
followed by secondary antibodies coupled to FITC. Filamentous actin
was stained with phalloidin conjugated to Rhodamine (1:1000) and
the nucleus was stained with DAPI (0.0125 μg/ml). Cells with the
Golgi located within a segment of 120° facing the wound were scored
as positive. To evaluate focal adhesion formation, astrocytes (15.000
cells) were stimulated with CAD WT, CAD shThy-1 or CAD shLuc cells
as reported [5]. Stimulated astrocytes were ﬁxed for 20 min and focal
adhesions were identiﬁed with the mouse anti-vinculin mAb, actin
stress ﬁbers with rhodamine-conjugated phalloidin and DAPI was
used to stain nuclei. Fluorophores were visualized by Olympus IX81
DSU microscopy, objective PLAPON 60× with the camara XM10. The
number of focal adhesions per cell and the average area per focal adhe-
sion were quantiﬁed using the ImageJ software program from National
Institutes of Health public domain as reported [6].
Cell morphology and Thy-1 expression in CAD WT, CAD shLuc and
CAD shThy-1 cells were evaluated using Rhodamine-conjugated
phalloidin and the anti-Thy-1 polyclonal antibody (1:200) followed
by secondary antibodies coupled to FITC, respectively.
2.7. Astrocytes treatment and immunoblot analysis
Astrocytes were seeded in 24-well plates and grown for 18 h to
70–80% conﬂuency. Then, cells were stimulated with Thy-1-Fc-Pro-
tein A (4 μg/0.4 μg) complexes or Thy-1 (RLE)-Fc-Protein A at dif-
ferent time points (0, 10, 20, 30, 40 and 60 min) using the same
positive and negative controls previously indicated. For immuno-
blot analysis, cells were washed with ice-cold PBS and lyzed with
Laemmli sample buffer [2% SDS, 10% Glycerol, 62.5 mM Tris–HCl
(pH 6.8), 5% β-mercaptoethanol and 0.01% bromophenol blue]
containing 1 mM sodium orthovanadate, 2 μg/ml antipain, 1 μg/ml
leupeptin, 10 μg/ml benzamidine, 1 mM PMSF and 50 μg/ml
Calyculin-A. Cell lysates were boiled for 5 min, subjected to 10%
SDS-PAGE and transferred to nitrocellulose membrane (BioRad,
Hercules, CA). The membranes were blocked with 5% gelatin in
TBS + 0.1% Tween 20 (TBS-T) or TBS-T 5% milk. Immunoblots
were performed by incubation of membranes with anti-p-Akt
(Cell signaling Danvers, MA) or anti-β-actin antibodies at 4 °C over-
night or 1 h at room temperature, followed by the appropriate sec-
ondary antibody conjugated to Horseradish peroxidase. The
peroxidase activity was revealed by enhanced chemiluminescence
using EZ-ECL (Biological Industries, Beit-Haemek Ltda., Israel). Fi-
nally, the image analysis system, Scion Image 4.0.2 (Center forInformation Technology, NIH, Bethesda, MD), was used to quantify
the changes in intensity of various bands.
2.8. Statistical analysis
Data indicate the mean ± s.e.m. of results from at least three in-
dependent experiments. Results were analyzed by non-parametric
test of Mann–Whitney to compare two groups and post-test of
Kruskal–Wallis to compare multiple groups. P value of less than
0.05 was considered to be signiﬁcantly different.
3. Results
3.1. Cell–cell interaction mediated by endogenous Thy-1 increases matrix
adhesion and migration of astrocytes
We have previously shown that cell–cell interaction mediated by
the cell adhesionmolecule Thy-1 increases adhesion to the extracellular
matrix in less than 20 min of stimulation and that these events require
the combined engagement of integrin and syndecan-4 receptors by
Thy-1 [8]. Because these initial events promote strong cell adhesion,
which would be predicted to inhibit cell migration, we tested the effect
of Thy-1 treatment on cell polarization and movement in a wound-
healing assay.
The effect of endogenous Thy-1 on astrocytemigrationwas studied by
co-culturing astrocytes with CAD cells, a neuron-derived cell line of
mouse origin that expresses high surface levels of Thy-1, as observed by
indirect immunoﬂuorescence analysis (Fig. 1A, top panel). Additionally,
CAD cellswith reduced levels of Thy-1, obtainedby lentiviral transduction
of shRNA that speciﬁcally target Thy-1 (shThy-1), were employed [27].
Confocal images of shThy-1 CAD cells lacking surface expression of
Thy-1 are shown (Fig. 1A, lower panel). Interestingly, the absence of
Thy-1 changed the shape of CAD cells decreasing their circularity. This
effect was not observed when using shRNA to Luciferase as a control
(shLuc) (Fig. 1B).
Unfortunately, after extended incubation periods, live CAD cells
adhere strongly to astrocytes and to the plate, making the study of
migratory events impossible after 24 h in co-culture. Therefore,
two different approaches were used to perform wound-healing as-
says stimulating astrocytes with whole CAD cells. First, ﬁxed CAD
cells were added to stimulate the wounded monolayer of
astrocytes. Then the ability of these ﬁxed CAD cells to induce for-
mation of focal adhesions in astrocytes was corroborated by immu-
noﬂuorescence analysis. Fixed CAD cells were found to behave like
live cells in the cell adhesion assays performed here and reported
previously, in that they increased both the number and size of
focal adhesions, as well as stress ﬁber formation compared to
non-stimulated control cells (Fig. 1C and [5,28]). In addition, both
CADWT cells and CAD cells transduced with shRNA targeting Lucif-
erase (CAD shLuc) increased number and the average size of focal
adhesions, while no effect was detected when using shRNA to
Thy-1 (CAD shThy-1, Fig. 1C). Because the results were comparable,
whether using ﬁxed or live cells to stimulate astrocyte adhesion,
ﬁxed CAD cells were utilized to induce cell migration in a
wound-healing assay. As found for adhesion, both CAD WT and
CAD shLuc cells induced cell migration, whereas no effect was
detected when using CAD shThy-1 cells (Fig. 1D). The second
approach was to add live CAD cells to the astrocytes prior to
scratching the cell monolayer for the wound-healing assay. Here,
we observed that the wounded area remained free of CAD cells
for the period of time during which astrocytes were stimulated to
migrate into the cell-free zone (data not shown). Astrocyte migra-
tion was similarly induced by either CADWT or CAD shLuc cells, but
for astrocytes stimulated with CAD shThy-1, migration was signiﬁ-
cantly reduced (Fig. 1E). Thus, both strategies using either ﬁxed or
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Fig. 1. Expression levels of endogenous Thy-1 determine CAD cell morphology as well as stimulation of focal adhesion formation and migration of DI TNC1 astrocytes. A) CAD cells
were transduced or not (CAD WT) with lentiviral vectors for shRNA Thy-1 (CAD shThy-1). Images are optical sections of cells obtained by confocal microscopy. Cells were stained
for Thy-1 (green) and F-actin (red). Scale bar: 20 μm. B) Morphological analyses were performed using ImageJ software. Graph shows the cell circularity index for wild type CAD
cells and for cells with Thy-1 silenced by different shRNA to Thy-1 (1, 2 and 3). Control values were obtained for cells transduced with shRNA Luciferase (CAD shLuc). Values are
means ± s.e.m. obtained from 3 independent experiments, whereby at least 100 cells were analyzed per experiment. Signiﬁcant differences **P b 0.01 compared to wild type cells,
##P b 0.01 compared to control cells. C) DI TNC1 cells were stimulated or not (NS) with CAD cells (CADWT) or CAD cells ﬁxed with 4% paraformaldehyde (CADWT f), CAD shLuc or
ﬁxed CAD shLuc (CAD shLuc f), CAD shThy-1 or ﬁxed CAD shThy-1 (CAD shThy-1 f), for 10 min. Focal adhesion formation was evaluated by immunoﬂuorescence using the
anti-vinculin monoclonal antibody followed by Alexa 488 anti-mouse IgG (green). Stress ﬁbers were stained with Rhodamine-conjugated phalloidin (red) and the nuclei with
DAPI (blue). Graphs showmean ± s.e.m. of number (upper) and average area (bottom) of focal adhesions. Signiﬁcant differences compared to NS (*P b 0.05), and to the respective
CAD shLuc controls (#P b 0.05) are indicated. D) Migration was evaluated using the wound-healing assay. DI TNC1 cells were stimulated or not (NS) with ﬁxed wild type CAD cells,
ﬁxed CAD shLuc or ﬁxed CAD shThy-1 cells for 24 h. Signiﬁcant differences compared to CAD shLuc (*P b 0.05) are indicated. E) Same as in D, but CAD cells were live (non-ﬁxed)
cells. Statistical signiﬁcance of difference between shThy-1 compared to control WT, P = 0.052.
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Thy-1 promoted astrocyte migration.3.2. Prolonged Thy-1 stimulation decreases astrocyte adhesion while cell
protrusions and polarity are established in an αVβ3 integrin and
syndecan-4 dependent manner
To study whether the effect of CAD cells on migratory events was
due to Thy-1, and to correlate these effects with those previously
reported for Thy-1 on astrocyte adhesion, we assessed the effects ofpuriﬁed Thy-1 on astrocytes in serum-free medium at different time
points.
The activation of RhoA, reportedly involved in promoting strong
cell adhesion and tension via focal adhesion and stress ﬁber forma-
tion [6], was found to be enhanced at 20 min but decreased at
60-minute incubation (Fig. 2A, graph). These activation-deactivation
events were paralleled by assembly-disassembly of focal adhesions
and stress ﬁbers, respectively (Fig. 2A, photos).
We then tested the effect of Thy-1 treatment on early events of
cell migration, namely the formation of ﬁlopodia and lamellipodia,
as well as polarization of cells present in the migrating front of a
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jugated to Protein-A or control preparations were added to a wound-
ed astrocyte monolayer. After 60 min of exposure to Thy-1-Fc in
serum-free medium, ﬁlopodia and lamellipodia formation were evi-
dent (Fig. 2B). These structures were not observed in cells incubated
with medium alone, which instead appeared to increase focaladhesion formation upon prolonged (≥60 min) incubation in
serum-free medium (Fig. 2B). Additionally, after 7 h of treatment,
cells became polarized as evidenced by positioning of the Golgi with-
in a 120 segment in front of the nucleus facing the leading edge in
those cells treated with Thy-1-Fc-Protein-A complexes, but not with
the negative control of this fusion protein, TRAIL-R2-Fc-Protein A
1414 M. Kong et al. / Biochimica et Biophysica Acta 1833 (2013) 1409–1420complex (Fig. 2C, photo and digital zoom for better visualization of
Golgi). As described for cell adhesion, polarization required the inter-
action of Thy-1 with both integrin and syndecan-4 receptors, since
the treatment with Thy-1-Fc mutated in the integrin-binding site
(RLD to RLE) or in the HBD (REKRK to AEAAA) did not induce cell po-
larization (Fig. 2C, graph). Medium in the presence of serum (FBS)
was used as a positive control (Fig. 2C, graph).A 
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values obtained for non-stimulated controls, indicated that either
serum or Thy-1-Fc, possessing intact RLD and REKRK sites, stimulated
cells tomigrate and populate the cell-free area (Fig. 3A, graph). Alterna-
tively, cell migration was not stimulated by Thy-1 mutated in either
integrin-binding site and/or in the HBD (Fig. 3A, graph). The require-
ment of both integrin and syndecan-4 binding to Thy-1 for cell migra-
tion was corroborated by testing Thy-1-induced migration following
pre-incubation of astrocytes with either anti-αV- or anti-β3-antibodies,
or pre-incubation of Thy-1 with Heparin (Fig. 3B) to block its HBD.
Control antibody had no effect on Thy-1 stimulated astrocyte migration
(Fig. 3B). Thus, as previously reported for adhesion [8], Thy-1-induced
cell polarization and migration are shown here to require interaction
of Thy-1 with both αVβ3 integrin and syndecan-4.
Thy-1-Fc-induced migration was dependent on sustained incuba-
tion with the stimulus, since the removal of Thy-1 at shorter time pe-
riods, led to decreased cell migration observed after 24 h (Fig. 3C).
With respect to the negative control using TRAIL-R2-Fc, the only sig-
niﬁcant difference was observed when Thy-1 stimulation was
maintained the entire 24-hour period (Fig. 3C). Furthermore, the ap-
pearance of cells in the wounded area could not be attributed to prolif-
eration, since these experiments were performed in the absence of
serum, under conditionswhere astrocyte proliferationwas not detected
within 24 h, as shown using the MTS assay (Fig. 3D, see bars of Thy-1,
TRAIL-R2 and NS) and the trypan blue exclusion assay (not shown).
On the contrary, in the presence of 3% serum, astrocytes divided every
24 h (Fig. 3D, FBS), indicating that in this case, wound closure could
be attributed to both migration and proliferation.
To examine DI TNC1 cells during active migration, we imaged
these cells by time-lapse confocal microscopy (Supplementary mate-
rial, Videos 1–3). Many cells in layers proximal to the wound stimu-
lated with Thy-1-Fc-Protein-A extended protrusions, spread and
migrated toward the cell-free area. In contrast, cells treated with
TRAIL-R2-Fc-Protein-A extended long protrusions during the ﬁrst
8 h, but then, only a few cells in the ﬁrst layer spread and migrated
to the wound. Astrocytes treated with 3% serum extended very long
processes. Also in this case, only cells of the ﬁrst layer spread and
moved toward the cell-free area. In addition, cells treated with
serum proliferated considerably more than in the other conditions,
as revealed also by the MTS assay (Fig. 3D). Noteworthy, cell prolifer-
ation in the presence of serum occurred to a large extent in those cells
located in the layers far from the wound. Daughter cells inserted
themselves in between cells of the monolayer, thereby pushing the
cells most proximal to the wound into the cell-free space. Thus, as
shown in Fig. 3, serum-stimulated closure of the cell-free area is the
consequence of both migration and proliferation, whereas Thy-1
stimulates cell migration and wound closure in the absence of
proliferation.
3.4. Migration requires Thy-1-integrin engagement and integrin-induced
FAK-dependent activation of PI3K
For astrocytes incubated with Thy-1, FAK phosphorylation on tyro-
sine 397 is enhanced [8]. Therefore, because PI3K reportedly binds to
this phosphorylated residue, we wondered whether PI3K, a kinase
known to participate in cell migration [30], was activated downstream
of FAK. To this end, cells were incubated for different periods of time
with Thy-1, and activation of PI3K was monitored by assessing phos-
phorylation of Akt, an important downstream target in the PI3K path-
way. Indeed, Akt phosphorylation increased in the presence of Thy-1
and required binding to integrin, since mutation of the integrin-
binding domain (RLE mutant), did not stimulate Akt phosphorylation
(Fig. 4A). Noteworthy, Thy-1mutated in theHBD,which possesses an in-
tact integrin-binding site (RLD) also promoted Akt phosphorylationwith
kinetics similar to the wild type Thy-1 fusion protein. A peak of phos-
phorylation was detected after 30 min of Thy-1 exposure (Fig. 4A).Thus, integrin but not syndecan-4 engagement triggers PI3K activation.
Moreover, Thy-1-induced Akt phosphorylation was inhibited by
LY294002 (Fig. 4B), a known inhibitor of PI3K. Interestingly, cell polariza-
tion (Fig. 4C) and cell migration (Fig. 4D) were also reduced by this in-
hibitor at concentrations reported to be speciﬁc for PI3K [31,32]. To test
whether PI3K activation occurred downstream of FAK activation, C14,
an inhibitor of FAK, was employed. For astrocytes incubated with C14
(5 μM), Y397-pFAK was reduced (Fig. 4E). At this same concentration,
C14 inhibited S473-pAkt induced by Thy-1 stimulation for 30 min
(Fig. 4F). These results suggest that the FAK/PI3K signaling pathway is ac-
tivated by Thy-1-integrin interaction and that this pathway is required to
induce astrocyte polarization and migration.
3.5. Thy-1 interaction with its receptors activates Rac1 and is necessary
for astrocyte migration
Another well-known participant in cell migration is the small
GTPase Rac1. Therefore, the kinetics of Rac1 activation were analyzed
after stimulation with Thy-1-Fc or mutated variants of this fusion
protein. Thy-1-RLD-Fc-integrin binding was found to reduce Rac1 ac-
tivation in the ﬁrst 30 min, while longer exposure to Thy-1 increased
Rac1 activity as observed at 60 and 120 min (Fig. 5A). Rac1 activity
found at both 60 and 120 min, but not at 40 min, was signiﬁcantly
different from values obtained at 30 min (P b 0.05; not indicated in
Fig. 5A). On the contrary, no signiﬁcant effect was observed at any
time point when using Thy-1-RLE-Fc, or the Thy-1 molecule mutated
in the HBD, Thy-1-AEAAA-Fc (Fig. 5A) compared to their respective
controls at time zero. These results suggest that Thy-1-engagement
of both integrin and syndecan-4 proteins is required to induce the
changes in activity of Rac1 GTPase. Since Rac1 is known to promote
formation of cell protrusions at the leading edge [33], we analyzed
lamellipodia formation upon stimulation with Thy-1-RLD-Fc, Thy-
1-RLE-Fc, or Thy-1-AEAAA-Fc at different time points. After 30 min
of stimulation with Thy-1-RLD-Fc, the number of cells with
lamellipodia doubled and continued to increase for up to the 2 h. Al-
ternatively, mutated Thy-1 did not alter the number of cells with
lamellipodia. These results indicate that only wild type Thy-1 induces
the formation of these structures (Fig. 5B and C). Additionally, the
Rac1 inhibitor, NSC, not only precluded Rac1 activation at 120 min
(Fig. 5D), but also completely abolished Thy-1 enhanced migration
(Fig. 5E). In a similar manner, Thy-1-induced astrocyte migration
was precluded by the over-expression of a EGFP-N17Rac1, a domi-
nant negative form of Rac1 (Fig. 5F). Thus, astrocyte motility stimu-
lated by Thy-1 requires the activation of the FAK/PI3K/Rac1
signaling pathway.
4. Discussion
Mechanistic insight to the events that control cell migration is re-
quired to comprehend processes including metastasis of cancer cells,
tissue formation during development and repair after wounding. In
this study, we describe that sustained Thy-1 mediated ligation of
integrin and syndecan-4 positively controls 2D cell migration of
astrocytes. Interestingly, the neuronal glycoprotein Thy-1 employs
binding motifs (RLD and HBD) similar to those reported for ECM pro-
teins and upon binding activates the FAK/PI3K/Rac1 signaling path-
way to increase astrocyte polarization and migration.
4.1. Thy-1 in cell adhesion and migration
Interactions of more than 100 components are an essential part of
the integrin signaling complexes. Based on these interactions, a hypo-
thetical integrin database named “adhesome” has been created [34].
Importantly, Thy-1 was identiﬁed as an adhesion-associated partner
of integrins, which is in good agreement with experimental evidence
showing that Thy-1 acts as an integrin ligand to mediate cell–cell
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interestingly, Thy-1 is the only identiﬁed integrin-binding partner
that also requires binding to syndecan-4 to promote cell adhesion
and migration (this study and [8,28]).
It is thought that integrins and syndecans connect the cytoskele-
ton to the plasma membrane, which transduces mechanical forces
from pliable ECM to the cytoskeleton [35]. In a 2D system, like the
one used in this study, the addition of Thy-1 containing cells or
Thy-1-Fc coupled to Protein-A beads [1,5] over the astrocyte mono-
layer may have affected the astrocytes by a mechanotransduction
pathway. However, Thy-1−/− cells did not induce focal adhesion
formation, while soluble Thy-1-Fc induced cellular responses,including cell adhesion and migration. This can be taken to indicate
that most likely Thy-1-mediated ligation of integrin and syndecan-4,
rather than mechanical stress, triggered the downstream signaling
events.
4.2. Thy-1-triggered cell signaling
Upon activation, PI3K phosphorylates phosphatidylinositol (4,5)-
bisphosphate (PIP2) resulting in the production of PIP3, which re-
cruits downstream effectors to the plasma membrane, such as Akt
[36]. In our studies, the phosphorylation of Akt at serine 473 was used
as a read-out for PI3K activation. Such pS473Akt phosphorylation was
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1417M. Kong et al. / Biochimica et Biophysica Acta 1833 (2013) 1409–1420dependent on prior FAK autophosphorylation and blocked by incuba-
tion with the PI3K-speciﬁc inhibitor LY294002. Additionally, this inhib-
itor also prevented Thy-1-induced cell polarization and migration,
suggesting the involvement of FAK and PI3K in this migratory process.
PI3K activation was also shown to depend on Thy-1-integrin, but
not Thy-1-syndecan interaction (Fig. 4), since Thy-1 mutated in
the integrin-binding site did not induce Akt phosphorylation.Alternatively, Thy-1 containing the RLD tripeptide, but not the HBD,
induced phosphorylation of Akt with similar kinetics and intensity
as observed for the wild type Thy-1 protein (Fig. 4A). Noteworthy,
Akt dephosphorylation occurred faster when induced by the
wild-type Thy-1-Fc than with the Thy-1 mutated in the HBD. Interest-
ingly, due to its association with PKCα, syndecan-4 has been de-
scribed as an integrin regulator, rather than as a co-receptor, and
AB
C
Fig. 6. Proposed model: Thy-1/αVβ3 integrin and Thy-1/syndecan-4 interactions induce cell adhesion and migration by sequential activation of RhoA and Rac1. A) αVβ3 integrin and
syndecan-4 bind to Thy-1 to induce focal adhesion and stress ﬁber formation [1]. Signaling events include activation of FAK, increased intracellular Ca2+ levels and translocation of
PKCα to the membrane, where it is suggested to activate RhoA [1,8,28]. Then, PKCα is depicted bound to syndecan-4, which enhances PKCα activity, further contributing to RhoA
activation and cell adhesion [8]. RhoA activation is observed in less than 20 min after Thy-1 stimulation [6]. B) Schematic representation of the kinetics of RhoGTPases activation
expressed in relative units (RU). Upon Thy-1 stimulation, RhoA is activated at 20 min and inactivated at 60 min; whereas, Rac1 shows decreased activity at 30 min and is activated
at 60 min. C) αVβ3 integrin and syndecan-4 bind to Thy-1 to induce cell migration. Signaling events here include activation of FAK, and PI3K and translocation of a yet unknown
RacGEF to the plasma membrane, which leads to activation of Rac1 and cell migration. Rac1 activation is observed after 30 min of Thy-1 stimulation (Fig. 5).
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integrin endocytosis [37]. Therefore, in the absence of syndecan-4 en-
gagement by Thy-1 mutated in the HBD, integrin desensitization
might be impaired, accounting for an elevated pS473Akt phosphory-
lation found after 60 min of stimulation (Fig. 4A).Another key player of the signaling cascade leading to cell migration
is Rac1 [38]. Here, we observed that Rac1 activation becomes detectable
after 30 min (Fig. 5A). Thus temporally, this event occurs after Akt
phosphorylation (Fig. 4A) and therefore, also after PI3K activation and
FAK autophosphorylation (see Section 4.3). Rac1 activation is reportedly
1419M. Kong et al. / Biochimica et Biophysica Acta 1833 (2013) 1409–1420regulated by syndecan-4 in a PKCα-dependent manner [39]. On the
other hand, syndecan-4 has been described as a primary receptor that,
once engaged, may alter β1 integrin signaling to produce changes in
cell adhesion [37,40,41]. Our data suggest that binding of Thy-1 only to
integrin in the absence of syndecan-4 ligation leads to phosphorylation
of Akt (Fig. 4), but neither to activation of Rac1 (Fig. 5A) nor to cellular
adhesion [8], polarization or migration (Fig. 2B and C). On the contrary,
binding of Thy-1 only to syndecan-4 without integrin engagement
[Thy-1(RLE)-Fc], does not lead to activation of any of the molecules or
cellular functions analyzed in these studies. Although Rac1 activation
shows a tendency to increase at 30 min of stimulation with this Thy-1
mutant, the differences were not statistically signiﬁcant (Fig. 5A). In ad-
dition, events known to be caused by Rac1 activation such as lamellipodia
formation [33], do not occur upon treatment with Thy-1(RLE)-Fc
(Fig. 5C). These results argue that for Thy-1-triggered events ligation
of syndecan-4 alone is insufﬁcient to trigger Rac1 activation and
lamellipodia formation.
4.3. Working model
We have previously shown that Thy-1 directly interacts with αVβ3
integrin triggering integrin clustering, tyrosine phosphorylation of
focal adhesion proteins, increased intracellular Ca2+ levels and PKCα
activity, activation of RhoA in astrocytes, thereby inducing focal adhe-
sion formation, cell attachment and spreading. Also, Thy-1 requires in-
teraction with syndecan-4 to stimulate focal adhesion formation,
possibly through complex formation of syndecan-4 with PKCα to fur-
ther activate RhoA and promote morphological changes and cell adhe-
sion (Fig. 6A). All these signaling events have been shown to occur in
less than 20 min upon addition of Thy-1 [1,5–8,28]. In the present
study, Thy-1 is shown to stimulate Rac1-dependent migration of astro-
cytes with distinct kinetics.While RhoA is activatedwithin 20 min after
Thy-1 stimulation and inactivated at 60 min, Rac1 activation shows
a drop in activity at 30 min and it is activated after 30 min of stimula-
tion with Thy-1 (Fig. 6B). We propose that after initial Thy-1-integrin
engagement leading to changes in cell adhesion and spreading
(Fig. 6A), phosphorylated FAK recruits PI3K, which increases PIP3 levels
at the plasmamembrane. PH domain-containing proteins, like RacGEFs
(not identiﬁed in this study), translocate to membrane-bound PIP3 and
activate Rac1, inducing cell migration (Fig. 6C). Evidence indicates that
Rac1 is the main GTPase activated downstream of syndecan-4 ligation
[39]. However, the link between Rac1 activation downstream of either
PI3K or syndecan-4 in our model, awaits further investigation.
Regulation of the cytoskeleton during cell migration has been
thought to involve Rac1-dependent formation of membrane protru-
sions at the leading edge, Cdc42-mediated ﬁlopodia formation and
cell polarization, and RhoA-dependent contractility at the rear of the
cell [33]. Imaging-techniques utilized to study activation of RhoGTPases
have uncovered a more complex scenario and generated considerable
controversy in the RhoGTPase ﬁeld [42]. However, supporting our
model of temporally distinct RhoA/Rac1 activation, new probes that
permitmonitoringRac1 activationwithout inducing cellular compensa-
tion mechanisms, indicate that Rac1 and RhoA activations are indeed
inversely correlated in cells [43].
Cells at the border of a wound-healing assay sense the environ-
mental changes and in the presence of serum, adapt by modifying
points of adhesion, changing cellular tension and inducing cell polar-
ization as well as migration to close the cell-free area. In this report,
we show that focal adhesion dynamics are also modiﬁed, in serum-
free medium, by signals generated from dorsally added neuron-like
cells, which induce astrocyte polarization and migration. The signals
received from neuronal cells need to be persistently present to induce
the cellular responses (Figs. 2 and 3), suggesting a requirement for re-
petitive stimulatory cycles to trigger cell polarization and migration.
Thus, exchange of information controlling migration over a matrix,
not only occurs as the consequence of interactions between theECM and the cell surface, but it is controlled by signals received
from other cells that contact the migrating cells. How cells integrate
these inputs received from different sites of the cell surface (dorsally
or ventrally) to generate apparently similar outcomes is an open
question that requires further investigation.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbamcr.2013.02.013.
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